THAR
Tharimmune Inc.
NASDAQ: THAR · HEALTHCARE · BIOTECHNOLOGY
$3.23
+3.53% today
Updated 2026-04-30
Market cap
$177.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.68
Dividend yield
—
52W range
$1 – $9
Volume
0.6M
Tharimmune Inc. (THAR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-2.25%
ROA
-1.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-1.53M | — | — | — |
| 2020 | $0.00 | $-2.42M | — | — | — |
| 2021 | $0.00 | $-2.21M | — | — | — |
| 2022 | $0.00 | $-8.47M | — | — | — |
| 2023 | $0.00 | $-9.32M | — | — | — |
| 2024 | $0.00 | $-12.20M | — | — | — |